IONS vs OPY · rev $226.6M vs P/E 13, rev $1.43B
Ionis Pharmaceuticals Inc (IONS) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
IONS currently screens at market cap $12.28B. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the IONS and OPY stock pages for the full models.
Not investment advice.